US Market News
4月前
Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTAFebruary 16, 2026 11:01 PM
PR Newswire (US)
LOS ANGELES, Feb. 16, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Charming Medical Limited ("Charming " or "the Company") (NASDAQ: MCTA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Shareholders who purchased shares of MCTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: October 21, 2025 to November 12, 2025 DEADLINE: February 17, 2026 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. The SEC suspended the trading of Charming shares based on the investigation of an alleged scheme to boost the Company's share price by supposed financial advisors touting shares on social media. Based on these facts, Charming's public statements were false and materially misleading throughout the class period.If you are a shareholder who suffered a loss, contact us to participate. WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.Join the case to recover your losses.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com
View original content:https://www.prnewswire.com/news-releases/charming-medical-limited-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--mcta-302689145.htmlSOURCE DJS Law Group LLP
Original: Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTA
US Market News
4月前
Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTAFebruary 12, 2026 11:12 PM
PR Newswire (US)
LOS ANGELES, Feb. 12, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Charming Medical Limited ("Charming " or "the Company") (NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Shareholders who purchased shares of MCTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.CLASS PERIOD: October 21, 2025 to November 12, 2025 DEADLINE: February 17, 2026 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. The SEC suspended the trading of Charming shares based on the investigation of an alleged scheme to boost the Company's share price by supposed financial advisors touting shares on social media. Based on these facts, Charming's public statements were false and materially misleading throughout the class period.If you are a shareholder who suffered a loss, contact us to participate .WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.Join the case to recover your losses.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. CONTACT: David J. SchwartzDJS Law Group274 White Plains Road, Suite 1Eastchester, NY 10709Phone: 914-206-9742Email: David@djslawllp.com
View original content:https://www.prnewswire.com/news-releases/charming-medical-limited-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--mcta-302687156.htmlSOURCE DJS Law Group LLP
Original: Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTA
US Market News
4月前
Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTAFebruary 9, 2026 4:01 PM
PR Newswire (US)
LOS ANGELES, Feb. 9, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Charming Medical Limited ("Charming " or "the Company") (NASDAQ: MCTA ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Shareholders who purchased shares of MCTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: October 21, 2025 to November 12, 2025 DEADLINE: February 17, 2026 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. The SEC suspended the trading of Charming shares based on the investigation of an alleged scheme to boost the Company's share price by supposed financial advisors touting shares on social media. Based on these facts, Charming's public statements were false and materially misleading throughout the class period.If you are a shareholder who suffered a loss, contact us to participate. WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.Join the case to recover your losses.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. CONTACT: David J. SchwartzDJS Law Group274 White Plains Road, Suite 1Eastchester, NY 10709Phone: 914-206-9742Email: David@djslawllp.com
View original content:https://www.prnewswire.com/news-releases/charming-medical-limited-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--mcta-302682205.htmlSOURCE DJS Law Group LLP
Original: Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTA
US Market News
4月前
Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTAFebruary 2, 2026 4:20 AM
PR Newswire (US)
LOS ANGELES, Feb. 2, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Charming Medical Limited ("Charming" or "the Company") (NASDAQ: MCTA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Shareholders who purchased shares of MCTA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: October 21, 2025 to November 12, 2025 DEADLINE: February 17, 2026 CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. The SEC suspended the trading of Charming shares based on the investigation of an alleged scheme to boost the Company's share price by supposed financial advisors touting shares on social media. Based on these facts, Charming's public statements were false and materially misleading throughout the class period.If you are a shareholder who suffered a loss, contact us to participate . WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.Join the case to recover your losses.This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: David@djslawllp.com
View original content:https://www.prnewswire.com/news-releases/charming-medical-limited-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--mcta-302675938.htmlSOURCE DJS Law Group LLP
Original: Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTA
Renee
7月前
MCTA SEC Suspension:
https://www.sec.gov/files/litigation/suspensions/2025/34-104176.pdf
It appears to the Securities and Exchange Commission that the public interest and the
protection of investors require a suspension in the trading of the securities of Charming Medical Limited (“MCTA”) (CIK No. 0002035992), a holding company incorporated in the British Virgin Islands and headquartered in Hong Kong, because of potential manipulation in the securities of MCTA effectuated through recommendations made to investors by unknown persons via social media to purchase, hold, and/or sell the securities of MCTA and to send screenshots documenting their transaction, which appear to be designed to artificially inflate the price and trading volume of the securities of MCTA. As of November 10, 2025, the common stock of MCTA is listed on the Nasdaq Capital Market under the symbol “MCTA.” The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed company.
THEREFORE, IT IS ORDERED, pursuant to Section 12(k) of the Exchange Act, that
trading in the securities of the above-listed company is suspended for the period from 4:00 AM ET on November 12, 2025, through 11:59 PM ET on November 25, 2025